Examkin

Question

Difficulty: MediumInsider Trading and Misuse of Material Nonpublic Information

A registered representative receives a telephone call from a customer who serves as a senior executive at a publicly traded biotechnology company. During the conversation, the customer discloses confidential, positive phase-3 clinical trial results that will not be released to the public until next week. Although the customer does not request any trade, the registered representative immediately purchases call options on the biotechnology company's stock for their personal trading account. Which of the following statements correctly describes the registered representative's liability under federal insider trading rules?

  1. The registered representative has committed an insider trading violation because executing securities transactions based on material nonpublic information violates federal law, regardless of employment status or who initiated the conversation.Answer
  2. B
    The registered representative is exempt from insider trading liability because they were a passive recipient of the information rather than an officer, director, or employee of the biotechnology company.
  3. C
    The registered representative did not violate insider trading prohibitions because statutory liability only attaches when an individual acts as a tipper by sharing the nonpublic information with third parties.
  4. D
    The registered representative is subject only to internal member firm rules regarding personal trading, as statutory insider trading penalties apply exclusively to corporate officers and directors.

Answer

The registered representative has committed an insider trading violation because executing securities transactions based on material nonpublic information violates federal law, regardless of employment status or who initiated the conversation.
Executing a trade in securities or related options while possessing material nonpublic information violates the Insider Trading and Securities Fraud Enforcement Act of 1988. A registered representative who receives confidential company information and uses it for personal financial gain is liable as a tippee, even if they do not work for the issuer.

Step-by-Step Solution

1
Evaluate the nature of the information disclosed during the call.
Unannounced phase-3 clinical trial results are material (substantially likely to affect investment decisions or stock price) and nonpublic.
Information remains nonpublic until it is broadly disseminated to the investing public.
2
Assess the registered representative's action relative to federal insider trading laws.
Buying call options in a personal account based on material nonpublic information constitutes illegal insider trading.
Under federal insider trading regulations, any person (including a tippee or registered representative) who trades while possessing material nonpublic information breaches duty and violates securities laws.

Key Concept

Tippee Liability and Misuse of Material Nonpublic Information
Rate this question

Topics

Insider Trading and Misuse of Material Nonpublic Information